Roth cannot conduct a capital raising for IHL until the the SEC has approved the Company’s Form F-1 (in essence a Prospectus). The SEC is the regulator and that part of the process has nothing to do with Roth.
In all likelihood the placement will simply occur in January and I’m guessing that’s perfectly acceptable to the majority of shareholders. It certainly would be to me. In fact, it could be a blessing in disguise because the first quarter will be a high news flow period.
I don’t understand why you’re acting like “chicken little” when there’s absolutely no reason to do so.
IHL Price at posting:
48.5¢ Sentiment: Buy Disclosure: Held
